How to buy Endologix stock

Endologix, Inc is a medical instruments & supplies business based in the US. Endologix shares (ELGX) are listed on the NASDAQ and all prices are listed in US Dollars. Endologix employs 488 staff and has a trailing 12-month revenue of around 0.00.

Endologix stock price (NASDAQ: ELGX)

Use our graph to track the performance of ELGX stocks over time.

Endologix shares at a glance

• Key figures

Information last updated 2021-01-22.

52-week range	$0.01 - $0.22
50-day moving average	$0.03
200-day moving average	$0.47
Wall St. target price	$0.88
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-7.27

Buy Endologix shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Endologix stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Endologix, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Endologix financials

Revenue TTM	$136.3 million
Gross profit TTM	$91.1 million
Return on assets TTM	-9.82%
Return on equity TTM	0%
Profit margin	-44.65%
Book value	$2.79
Market capitalisation	$4.2 million

TTM: trailing 12 months

Shorting Endologix shares

There are currently 343,574 Endologix shares held short by investors – that's known as Endologix's "short interest". This figure is 45.3% up from 236,448 last month.

There are a few different ways that this level of interest in shorting Endologix shares can be evaluated.

Endologix's "short interest ratio" (SIR)

Endologix's "short interest ratio" (SIR) is the quantity of Endologix shares currently shorted divided by the average quantity of Endologix shares traded daily (recently around 377553.84615385). Endologix's SIR currently stands at 0.91. In other words for every 100,000 Endologix shares traded daily on the market, roughly 910 shares are currently held short.

However Endologix's short interest can also be evaluated against the total number of Endologix shares, or, against the total number of tradable Endologix shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Endologix's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Endologix shares in existence, roughly 20 shares are currently held short) or 0.0202% of the tradable shares (for every 100,000 tradable Endologix shares, roughly 20 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Endologix.

Find out more about how you can short Endologix stock.

Endologix share dividends

We're not expecting Endologix to pay a dividend over the next 12 months.

Have Endologix's shares ever split?

Endologix's shares were split on a 1:10 basis on 5 March 2019. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Endologix shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Endologix shares which in turn could have impacted Endologix's share price.

Endologix share price volatility

Over the last 12 months, Endologix's shares have ranged in value from as little as $0.01 up to $0.22. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Endologix's is 0.735. This would suggest that Endologix's shares are less volatile than average (for this exchange).

Endologix overview

Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. The company offers minimally-invasive endovascular aneurysm repair (EVAR), including AFX (Anatomical Fixation) endovascular AAA system, which is a minimally invasive delivery system; VELA Proximal Endograft, which is designed for the treatment of proximal aortic neck anatomies with AFX; and the Ovation abdominal stent graft system. It also provides endovascular aneurysm sealing system (EVAS) product that is based on the Nellix EVAS system to seal the aneurysm, and provides blood flow to the legs through two blood lumens. In addition, the company offers proximal aortic extensions and limb extensions, which allow physicians to customize the implant to fit the patient's anatomy; and accessories to facilitate the delivery of its EVAR and EVAS products, including compatible guidewires, inflation devices, and snares. It sells its products through direct sales force, and a network of third party distributors and agents. The company was formerly known as Radiance Medical Systems, Inc.

Frequently asked questions

What percentage of Endologix is owned by insiders or institutions?
Currently 4.693% of Endologix shares are held by insiders and 74.715% by institutions. How many people work for Endologix?
Latest data suggests 488 work at Endologix. When does the fiscal year end for Endologix?
Endologix's fiscal year ends in December. Where is Endologix based?
Endologix's address is: 2 Musick, Irvine, CA, United States, 92618 What is Endologix's ISIN number?
Endologix's international securities identification number is: US29266S3040 What is Endologix's CUSIP number?
Endologix's Committee on Uniform Securities Identification Procedures number is: 14160K102